Início › Obesidade › Nova York › Rochester
Ensaios clínicos de Obesidade em Rochester, NY
14 estudos para Obesidade estão buscando participantes em locais em Rochester e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
RecrutandoFase 2
- Rochester Clinical Research /ID# 282484, Rochester
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
RecrutandoFase 2
- Rochester Clinical Research, Rochester
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RecrutandoFase 3
- Rochester Clinical Research, LLC, Rochester
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecrutandoFase 3
- Rochester Clinical Research, Rochester
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RecrutandoFase 3
- Rochester Clinical Research, LLC, Rochester
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
RecrutandoFase 3
- Rochester Clinical Research, LLC, Rochester
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RecrutandoFase 2
- Rochester Clinical Research, LLC, Rochester
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RecrutandoFase 2
- Rochester Clinical Research, LLC, Rochester
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RecrutandoFase 3
- Rochester Clinical Research, Rochester
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
RecrutandoFase 3
- Kailera Clinical Site, Rochester
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecrutandoFase 3
- Rochester Clinical Research, Rochester
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecrutandoFase 3
- University of Rochester, Rochester
Body Composition Related Evaluation of Airway Tone and Hyper-rEactivity Using Oscillometry
RecrutandoEstudo observacional
- University of Rochester Medical Center, Rochester
Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Eastman Institute for Oral Health, University of Rochester, Rochester
Ensaios de Obesidade em outras cidades
- Houston, TX43 estudos
- Chicago, IL41 estudos
- New York City, NY40 estudos
- San Antonio, TX40 estudos
- Washington, DC33 estudos
- Orlando, FL31 estudos
- Dallas, TX30 estudos
- Boston, MA28 estudos
- Las Vegas, NV27 estudos
- Miami, FL27 estudos
- Baltimore, MD25 estudos
- Jacksonville, FL25 estudos
Outros estudos em Rochester
- Leucemia Mieloide Aguda16 estudos
- Câncer de Pulmão15 estudos
- Câncer de Mama15 estudos
- Câncer (todos os tipos)14 estudos
- Câncer de Pulmão de Não Pequenas Células13 estudos
- Sobrepeso13 estudos
- Câncer de Próstata10 estudos
- Mieloma Múltiplo8 estudos
- Câncer Metastático8 estudos
- Câncer de Pâncreas7 estudos
- Distrofia Miotônica7 estudos
- Câncer de Bexiga7 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.